Statement of HIVMA Chair Dr. W. David Hardy on USPSTF final PrEP recommendation

The U.S. Preventive Services Task Force’s final “A” grade recommendation for pre-exposure prophylaxis (PrEP) for HIV represents a critical milestone for improving access to PrEP for individuals with health insurance coverage and to advancing the administration’s initiative to end HIV as an epidemic.  

HHS Fetal Tissue Research Ban Threatens Progress Toward Cure for HIV, Other Life-threatening Diseases

The Department of Health and Human Services’ announcement Wednesday that it will halt funding for research involving the use of human fetal tissue conducted within the National Institutes of Health, and review funding for research at extramural research universities with potential new restrictions, will significantly imperil our most promising strategies to develop a cure for HIV and other life-threatening diseases, while soundly undermining the administration’s stated commitment to ending the HIV epidemic.

HIVMA submits joint comments for Federal STD Action Plan

HIVMA, IDSA, PIDS, National Coalition of STD Directors, and Treatment Action Group respond to HHS request for information during development of the first Federal STD Action Plan, highlight high costs and key barriers to prevention, treatment and care.

Ebola Crisis in DRC Demands Immediate, Ongoing Investments

The Ebola outbreak in the Democratic Republic of Congo’s North Kivu province remains uncontrolled despite heroic efforts on the part of international and local responders.

Allowing Discrimination, Administration Proposals Threaten Transgender Health and Progress Against HIV Epidemic

The administration’s proposals to weaken protections for transgender individuals that improve their access to health care, housing and shelter services are discriminatory, destructive and pose significant, threats to the president’s stated goal of ending HIV as an epidemic in the U.S

Testimony Submitted by HIVMA Chair David Hardy for the House Committee on Oversight and Reform Hearing on PrEP

Thank you for the opportunity to submit testimony for the record on behalf of the HIV Medicine Association (HIVMA) regarding the role of drug pricing and associated drug costs as barriers to people at higher risk for HIV accessing Pre-Exposure Prophylaxis (PrEP)

HHS “Conscience Rights” Rule Threatens Public Health

The final rule released by the U.S. Department of Health and Human Services Thursday affirming support for health care providers who deny care and treatment based on their religious beliefs reinforces stigma and discrimination, with clear negative impacts to the administration’s initiative to End the HIV Epidemic within the next decade.

House Subcommittee Spending Bill Prioritizes Ending the HIV Epidemic

The House Appropriations Labor-Health and Human Services subcommittee advanced a bill Tuesday that would provide essential support for the administration’s initiative to end the American HIV epidemic in the next 10 years.

Experts Call for Strengthened, Integrated Strategies Addressing “Converging Public Health Crisis” of Opioid, ID Epidemics

Citing the spread of infections linked to rising rates of opioid use across the country including HIV, viral hepatitis, skin and soft tissue infections, bone and joint infections and endocarditis

Vaccine Avoidance Endangers Individual and Public Health

The Kentucky governor’s decision this week to voice support for the irresponsible practice of deliberately exposing children to chickenpox as an alternative to vaccination is gravely concerning.

Ebola Hearing Highlights Global Health Investment Payoffs, Ongoing Needs

The Senate Appropriations Labor, Health and Human Services Subcommittee’s hearing on the continuing Ebola epidemic in the Democratic Republic of Congo brought the unprecedented challenges posed by the current outbreak, as well as the responses needed before policymakers Thursday.

Administration Budget Proposal Takes Steps Towards Ending Epidemic, Undermined by Concurrent Cuts

The White House budget proposal for 2020 recommends increases to the domestic HIV programs at the U.S. Centers for Disease Control and Prevention, the Health Resources and Services Administration and Indian Health Services that will be essential to keeping the administration’s promise of ending our nation’s HIV epidemic in the next decade.